Serum bilirubin levels and UGT1A1 promoter variations in patients with schizophrenia

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 449-450

  Vítek, Libor ^a   Novotná, Michaela ^a   Leníĉek, Martin ^a   Novotnỳ, Ladislav ^a   Eberová, Jitka ^a   Petrášek, Jan ^a   Jirsa, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE;

BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENVIRONMENTAL FACTOR; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; LETTER; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROMOTER REGION; RECEIVER OPERATING CHARACTERISTIC; SCHIZOPHRENIA; BLOOD; CASE CONTROL STUDY; CZECH REPUBLIC; GENETICS;

BILIRUBIN; CASE-CONTROL STUDIES; CZECH REPUBLIC; FEMALE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; PROMOTER REGIONS, GENETIC; SCHIZOPHRENIA;

EID: 77955490786     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.12.008     Document Type: Letter

References (5)

1. Jirsa M., Petrásek J., Vítek L. Linkage between A(TA)TAA and -3279T>G mutations in UGT1A1 is not essential for pathogenesis of Gilbert syndrome. Liver International 2006, 26:1302-1303.
2. Miyaoka T., Seno H., Maeda T., Itoga M., Horiguchi J. Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): 3 case reports. The Journal of Clinical Psychiatry 2000, 61:299-300.
3. Müller N., Schiller P., Ackenheil M. Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 1991, 24:225-228.
4. Pae C.U., Paik I.H., Lee C., Kim J.J., Lee C.U. Decreased plasma antioxidants in schizophrenia. Neuropsychobiology 2004, 50:54-56.
5. Yao J.K., Reddy R., McElhinny L.G., van Kammen D.P. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research 1998, 32:1-8.